LIST OF TABLES
TABLE 1 NUMBER OF FORMULATION COMPONENTS FOR TOPICAL DRUG PRODUCTS MENTIONED BELOW:
TABLE 2 NUMBER AND DISTRIBUTION OF PERSONS AGED 60 YEARS OR OVER BY REGION, IN 2017 AND 2050
TABLE 3 LIST OF APPROVED TOPICAL DRUGS
TABLE 4 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE , 2017-2026 (USD MILLION)
TABLE 5 NORTH AMERICA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 6 NORTH AMERICA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 7 NORTH AMERICA SEMI-SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 8 NORTH AMERICA SEMI-SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 9 NORTH AMERICA LIQUID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 10 NORTH AMERICA LIQUID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 11 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION , 2017-2026 (USD MILLION)
TABLE 12 NORTH AMERICA SKIN INFECTIONS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 13 NORTH AMERICA DERMATITIS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 14 NORTH AMERICA ANTIAGING IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 15 NORTH AMERICA ACNE IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 16 NORTH AMERICA HYPERPIGMENTATION IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 17 NORTH AMERICA ROSACEA IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 18 NORTH AMERICA SKIN CANCER IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 19 NORTH AMERICA PSORIASIS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 20 NORTH AMERICA ONYCHOMYCOSIS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 21 NORTH AMERICA OTHERS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 22 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY , 2017-2026 (USD MILLION)
TABLE 23 NORTH AMERICA BRANDED IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 24 NORTH AMERICA GENERIC IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 25 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 26 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 27 NORTH AMERICA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 28 NORTH AMERICA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 29 NORTH AMERICA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 30 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 31 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
TABLE 32 U.S. RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 33 U.S. SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 34 U.S. LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 35 U.S. SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 36 U.S. RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 37 U.S. RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
TABLE 38 CANADA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 39 CANADA SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 40 CANADA LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 41 CANADA SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 42 CANADA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 43 CANADA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)
TABLE 44 MEXICO RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 45 MEXICO SEMI-SOLID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 46 MEXICO LIQUID DRUGS IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 47 MEXICO SOLID IN RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017-2026 (USD MILLION)
TABLE 48 MEXICO RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 49 MEXICO RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET, BY CATEGORY, 2017-2026 (USD MILLION)

LIST OF FIGURE

LIST OF FIGURES
FIGURE 1 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: GEOGRAPHICAL SCOPE
FIGURE 3 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: DATA TRIANGULATION
FIGURE 4 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: DROC ANALYSIS
FIGURE 5 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 6 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 7 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET
FIGURE 9 TOTAL NUMBER OF COMPANIES WITH ACTIVE PIPELINE (2015 TO 2017)
FIGURE 10 TOTAL NUMBER OF COMPANIES WITH ACTIVE PIPELINE (2012-2017)
FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE INCREASING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 12 INCREASING PREVALENCE OF SKIN DISEASES OR CONDITIONS, RISING AGING POPULATION AND GROWTH IN TOPICAL DRUG DELIVERY ARE EXPECTED TO DRIVE THE NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 13 SEMI-SOLID IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA DERMATOLOGY DRUG DELIVERY MARKET IN 2019 & 2026
FIGURE 14 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: BY PRODUCT TYPE, 2018
FIGURE 15 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: BY APPLICATION, 2018
FIGURE 16 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: BY CATEGORY, 2018
FIGURE 17 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: SNAPSHOT (2018)
FIGURE 18 NORTH AMERICA RX DERMATOLOGY TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE 2018 (%)